---
figid: PMC3724399__nihms-398695-f0001
figlink: /pmc/articles/PMC3724399/figure/F1/
number: Figure 1
caption: The PI3K/Akt/mTOR pathway. Activation of a receptor tyrosine kinase (RTK)
  leads to increased activity of PI3 kinase complexes (p85 and p110) which in turn
  converts phosphatidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinositol-3,4,5-trisphosphate
  (PIP3); a reaction that is antagonized by the tumor suppressor Pten. PIP3 then phosphorylates
  and activates Akt, which through a series of subsequent phosphorylation events leads
  to activation of the mTOR complexes, mTORC1 and mTORC2. mTOR complexes are also
  kinases that activate via phosphorylation substrates such as S6 and 4E-BP1 that
  increase transcription of growth promoting genes. Points of pharmacologic inhibition
  that are currently the focus of drug development are shown.
pmcid: PMC3724399
papertitle: Targeting the PI3K/Akt/mTOR pathway for breast cancer therapy.
reftext: Justin Cidado, et al. J Mammary Gland Biol Neoplasia. ;17(0):205-216.
pmc_ranked_result_index: '20785'
pathway_score: 0.9592972
filename: nihms-398695-f0001.jpg
figtitle: PI3K/Akt/mTOR pathway
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3724399__nihms-398695-f0001.html
  '@type': Dataset
  description: The PI3K/Akt/mTOR pathway. Activation of a receptor tyrosine kinase
    (RTK) leads to increased activity of PI3 kinase complexes (p85 and p110) which
    in turn converts phosphatidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinositol-3,4,5-trisphosphate
    (PIP3); a reaction that is antagonized by the tumor suppressor Pten. PIP3 then
    phosphorylates and activates Akt, which through a series of subsequent phosphorylation
    events leads to activation of the mTOR complexes, mTORC1 and mTORC2. mTOR complexes
    are also kinases that activate via phosphorylation substrates such as S6 and 4E-BP1
    that increase transcription of growth promoting genes. Points of pharmacologic
    inhibition that are currently the focus of drug development are shown.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KRAS
  - MLST8
  - PTEN
  - PIK3CB
  - AKT2
  - RICTOR
  - MAPKAP1
  - HRAS
  - PIK3R3
  - PIK3CG
  - PIK3R4
  - NRAS
  - AKT1
  - MTOR
  - AKT3
  - PIK3CA
  - PIK3CD
  - PIK3R5
  - RPS6KB2
  - RHEB
  - PIK3R6
  - TSC2
  - RPS6KB1
  - TSC1
  - SART3
  - Glucose
  - Cancer
genes:
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: Pten
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: Rictor
  symbol: RICTOR
  source: hgnc_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: TSC1
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
chemicals:
- word: Glucose
  source: MESH
  identifier: D005947
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
